Clinical Trials Browser

OTHER × Has results × Bone Diseases, Metabolic × Clear all

Frailty, Arthritis, Bone Diseases, Metabolic, Cardiovascular Diseases, Chronic Disease, Diabetes Mellitus, Heart Failure, Hypertension, Kidney Diseases, Neoplasms, Osteoporosis, Stroke

NCT00452439 2020-12-28

A Study of Actonel for the Prevention of Bone Loss

Phase 3 Completed

72 enrolled 8 charts

LymphoidOther hematologic neoplasm

Bone Diseases, Metabolic, Leukemia, Lymphoma, Osteoporosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00824993 2018-09-13

Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients

Phase 3 Completed

78 enrolled 7 charts

Other hematologic neoplasm

Bone Diseases, Metabolic, Osteoporosis, Hematologic Neoplasms

NCT00485953 2017-10-13

REBBeCA II

Phase 4 Completed

109 enrolled 11 charts

Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

NCT00352846 2013-07-02

Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss

Phase 3 Completed

135 enrolled 4 charts

Lymphoid

Bone Diseases, Metabolic, Lymphoma, Lymphoma, Non-Hodgkin

NCT00145704 2013-04-08

Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density

Phase NA Terminated

6 enrolled 3 charts

Endocrine

Bone Diseases, Metabolic, Dwarfism, Pituitary

NCT00766532 2012-09-14

Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?

Phase 4 Completed

12 enrolled 5 charts

Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis, Fractures, Bone

Clinical Trials

MoveStrong

A Study of Actonel for the Prevention of Bone Loss

Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients

REBBeCA II

Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss

Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density

Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?